The McKnight Brain Institute’s signature programs in age-related cognitive decline, developmental disorders, sensory dysfunction, pain, and neuropsychiatric diseases including substance use disorders. The MBI is dedicated to accelerating discoveries to enhance brain health and develop innovative therapies.
Center for Addiction Research & Education (CARE)
CARE facilitates collaborative addiction research across programs to define more effective prevention, intervention, and recovery programs.
Center for Advanced Pain Therapeutics and Research (CAPToR)
CAPToR is dedicated to discovering new non-addictive pain therapeutics to improve lives and combat the growing concern of chronic pain through pre-clinical interdisciplinary collaboration of pain experts.
Center for Autism and Neurodevelopment (CAN)
CAN provides centralized transdisciplinary diagnostic and clinical treatment services for children and adults with neurodevelopmental disorders and accelerates research efforts.
Center for Cognitive Aging and Memory Clinical Translational Research (CAM Center)
The CAM Center is devoted to improving the quality of life for seniors by alleviating cognitive changes due to the normal aging process that affect the vast majority of people and differ from dementia and other diseases affecting the brain.
Learn more about the CAM Center.
Center for OCD, Anxiety & Related Disorders (COARD)
COARD brings together an interdisciplinary group of researchers and clinicians who conduct clinical and translational research in obsessive compulsive and anxiety disorders.
Florida Chemical Senses Institute (FCSI)
The Florida Chemical Senses Institute is a statewide institute dedicated to advancing our understanding of the chemical senses and how they are accomplished across all ranges.
Pain Research and Intervention Center of Excellence (PRICE)
PRICE serves as home to scientists, clinicians, and trainees dedicated to improving the understanding and treatment of pain, and includes more than 30 extramurally-funded investigators pursuing a broad range of studies.
Recent News
In The Conversation, Dr. Ramon Sun discusses his study reporting an increased mortality risk among Alzheimer’s patients using Glucosamine.
Dr. Kimberly Alonge’s research explores the role of the brain’s extracellular matrices in neuro disorders as well as in aging, obesity and diabetes.
Research team seeks to improve clinicians’ ability to distinguish between diseases involving dementia.
